CytomX Therapeutics Inc. (CTMX)
0.65
-0.03 (-4.02%)
At close: Mar 03, 2025, 3:59 PM
0.65
0.12%
After-hours: Mar 03, 2025, 04:06 PM EST
CytomX Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 17.17M | 193.65M | 205.53M | 191.86M | 188.43M | 247.58M | 177.55M | 104.64M | 59.82M | 64.4M | 8.7M |
| Short-Term Investments | 157.34M | n/a | 99.7M | 124.26M | 107.72M | 188.55M | 196.56M | 77.29M | 126.89M | n/a | n/a |
| Long-Term Investments | n/a | 917K | 917K | 917K | 917K | 917K | 917K | 917K | 995K | n/a | n/a |
| Other Long-Term Assets | 1M | -3.57M | -3.71M | -3.37M | 2.93M | 238K | 957K | 2.66M | -115K | 492K | 148K |
| Receivables | 3.43M | 35.99M | 790K | 798K | 13K | 97K | 10.14M | 2.31M | 744K | 1.88M | 237K |
| Inventory | n/a | n/a | 1.00 | 1.00 | 1.00 | n/a | 1.00 | 1.00 | 1.00 | 100K | 100K |
| Other Current Assets | 5M | 7.47M | 8.57M | 14.19M | 14.35M | 18.5M | 8.7M | 3.9M | 4.6M | 582K | 326K |
| Total Current Assets | 182.94M | 237.1M | 310.3M | 324.01M | 303.33M | 445.48M | 388.6M | 188.15M | 189.75M | 66.85M | 9.27M |
| Property-Plant & Equipment | 16.18M | 21.02M | 25.32M | 29.45M | 32.75M | 6.93M | 4.22M | 4.39M | 3.48M | 3.02M | 2.07M |
| Goodwill & Intangibles | 1.68M | 1.82M | 1.97M | 2.12M | 2.26M | 2.41M | 2.55M | 2.7M | 2.7M | 2.7M | 2.7M |
| Total Long-Term Assets | 18.86M | 23.79M | 29.11M | 34.65M | 37.95M | 11.63M | 9.04M | 10.98M | 7.46M | 6.21M | 4.92M |
| Total Assets | 201.79M | 260.89M | 339.41M | 358.66M | 341.28M | 457.11M | 397.64M | 199.13M | 197.22M | 73.06M | 14.18M |
| Account Payables | 1.46M | 2.81M | 2.82M | 3M | 4.16M | 5.13M | 4.21M | 6.6M | 4.7M | 1.92M | 930K |
| Deferred Revenue | 132.27M | 121.27M | 69.26M | 74.87M | 51.38M | 52.71M | 40.56M | 20.35M | 6.13M | 6.13M | 857K |
| Short-Term Debt | 4.59M | 4.08M | 3.62M | 3.19M | 2.81M | n/a | n/a | n/a | n/a | 1.42M | 1.26M |
| Other Current Liabilities | 17.6M | 24.45M | 30.62M | 19.86M | 27.24M | 26.72M | 16.38M | 8.82M | 4.91M | 1.7M | 1.13M |
| Total Current Liabilities | 155.91M | 152.61M | 106.32M | 100.92M | 85.59M | 97.91M | 61.15M | 35.77M | 15.74M | 11.16M | 4.17M |
| Long-Term Debt | 9.38M | 27.95M | 36.11M | 43.35M | 49.74M | n/a | n/a | n/a | n/a | 1.57M | 2.94M |
| Other Long-Term Liabilities | 3.89M | -13.97M | 100.23M | -21.68M | -24.02M | 3.05M | 1.9M | 566K | 198K | 77.54M | 46.21M |
| Total Long-Term Liabilities | 93.33M | 194.03M | 143.72M | 207.94M | 204.58M | 228.32M | 266.6M | 84.88M | 55.41M | 140.44M | 54.29M |
| Total Liabilities | 249.24M | 346.64M | 250.03M | 308.86M | 290.17M | 326.23M | 327.75M | 120.65M | 71.15M | 151.6M | 58.46M |
| Total Debt | 13.97M | 18.06M | 18.06M | 24.87M | 24.87M | n/a | n/a | n/a | n/a | 2.99M | 4.2M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -723.45M | -722.88M | -533.72M | -450.12M | -417.23M | -314.98M | -219.47M | -176.37M | -117.47M | -78.14M | -43.88M |
| Comprehensive Income | 95K | 10K | -242K | -47K | 57K | -93K | -94K | -27K | -76K | -404K | -399K |
| Shareholders Equity | -47.45M | -85.75M | 89.38M | 49.8M | 51.11M | 130.88M | 69.9M | 78.48M | 126.07M | -78.54M | -44.28M |
| Total Investments | 157.34M | 917K | 99.7M | 124.26M | 107.72M | 188.55M | 196.56M | 77.29M | 126.89M | n/a | n/a |